| Literature DB >> 34782579 |
Wen-Yuan Shen1, Xuan-Hao Fu1, Jun Cai2, Wen-Chang Li2, Bao-You Fan1, Yi-Lin Pang1, Chen-Xi Zhao1, Muhtidir Abula1, Xiao-Hong Kong3, Xue Yao1, Shi-Qing Feng1.
Abstract
Zebrafish are an effective vertebrate model to study the mechanisms underlying recovery after spinal cord injury. The subacute phase after spinal cord injury is critical to the recovery of neurological function, which involves tissue bridging and axon regeneration. In this study, we found that zebrafish spontaneously recovered 44% of their swimming ability within the subacute phase (2 weeks) after spinal cord injury. During this period, we identified 7762 differentially expressed genes in spinal cord tissue: 2950 were up-regulated and 4812 were down-regulated. These differentially expressed genes were primarily concentrated in the biological processes of the respiratory chain, axon regeneration, and cell-component morphogenesis. The genes were also mostly involved in the regulation of metabolic pathways, the cell cycle, and gene-regulation pathways. We verified the gene expression of two differentially expressed genes, clasp2 up-regulation and h1m down-regulation, in zebrafish spinal cord tissue in vitro. Pathway enrichment analysis revealed that up-regulated clasp2 functions similarly to microtubule-associated protein, which is responsible for axon extension regulated by microtubules. Down-regulated h1m controls endogenous stem cell differentiation after spinal cord injury. This study provides new candidate genes, clasp2 and h1m, as potential therapeutic intervention targets for spinal cord injury repair by neuroregeneration. All experimental procedures and protocols were approved by the Animal Ethics Committee of Tianjin Institute of Medical & Pharmaceutical Sciences (approval No. IMPS-EAEP-Q-2019-02) on September 24, 2019.Entities:
Keywords: axon regeneration; clasp2; endogenous neural stem cells; h1m; microtubule; nanog; neural regeneration; neurogenesis; spinal cord injury; subacute phase
Year: 2022 PMID: 34782579 PMCID: PMC8643032 DOI: 10.4103/1673-5374.327360
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135
Primers for real-time qPCR used in this study
| Gene | Sequence (5’–3’) | Product size (bp) |
|---|---|---|
|
| Forward: GTG TAG GCG TGG ACT GTG GT | 20 |
| Reverse: TGG GAG TCA ACC AGG ACA AAT A | 22 | |
|
| Forward: CTG GTG TAA GCC TAG TTC TGG | 21 |
| Reverse: GGG TCG CAA ACA TCT CGT | 18 | |
|
| Forward: GGA AAC TGG GAC TGT CTG | 18 |
| Reverse: TTG CCA TCC TTG TCG TAA T | 19 | |
|
| Forward: AGG AAC AAG CCG ACT ACT G | 19 |
| Reverse: AAG AGC GAG CGG GTG AAT | 18 | |
|
| Forward: ATA CCC AAA CAC TCA CCC | 18 |
| Reverse: CAC AGA CTG GCA TCT CAC | 18 | |
|
| Forward: GCT CTG GCT GAG AAA CGT | 18 |
| Reverse: CCT TGT TCT GCT CCA TCT T | 19 | |
|
| Forward: TGG AGG CAC ATA AAG ACC | 18 |
| Reverse: TGA CTG GAT GAT GGG ACA | 18 | |
|
| Forward: TTT CCT TTG TGC CTG TCG | 18 |
| Reverse: CCT CAT CCT GAT TTA CGC | 18 | |
|
| Forward: AGC TCC TGA AGA CTC CAA C | 19 |
| Reverse: TAG CCA CGA ATA GCC TGA | 18 | |
|
| Forward: CAG AAC AGC AGC AGT GGC | 18 |
| Reverse: TTT CCG AAT CCT CCC TTA C | 19 |
GO pathways enrichment of DEGs in 2 weeks after injury
| GO term | Description | Count | |
|---|---|---|---|
|
| |||
| GO:0070469 | Respiratory chain | 43 | 2.26E-16 |
| GO:0045202 | Synapse | 109 | 1.69E-15 |
| GO:0097458 | Neuron part | 146 | 1.77E-14 |
| GO:0032989 | Cellular component morphogenesis | 152 | 6.59E-11 |
| GO:0043235 | Receptor complex | 69 | 8.89E-08 |
| GO:0022839 | Ion gated channel activity | 77 | 9.56E-07 |
| GO:0008137 | NADH dehydrogenase (ubiquinone) activity | 14 | 1.24E-06 |
| GO:0007155 | Cell adhesion | 109 | 1.71E-06 |
| GO:0030029 | Actin filament | 101 | 2.16E-06 |
| GO:0005509 | Calcium ion binding | 124 | 9.1E-06 |
|
| |||
| GO:0006396 | RNA processing | 238 | 4.82E-63 |
| GO:0006259 | DNA metabolic process | 201 | 2.04E-59 |
| GO:0051276 | Chromosome organization | 217 | 1.35E-56 |
| GO:0022402 | Cell cycle process | 194 | 5.86E-53 |
| GO:0005694 | Chromosome | 197 | 8.15E-49 |
| GO:0030684 | Preribosome | 56 | 4.37E-34 |
| GO:0000003 | Reproduction | 107 | 2.18E-29 |
| GO:0005654 | Nucleoplasm | 169 | 2.04E-27 |
| GO:0140098 | Catalytic activity, acting on RNA | 109 | 2.08E-24 |
| GO:0098687 | Chromosomal region | 61 | 4.19E-24 |
There are top 10 significantly enriched gene GO terms of up-regulated and down-regulated DEGs in spinal cord injury. DEG: Differentially expressed genes; GO: gene ontology.
KEGG pathways enrichment of DEGs in 2 weeks after injury
| KEGG Pathway | Description | Count | |
|---|---|---|---|
|
| |||
| dre00190 | Oxidative phosphorylation | 57 | 2.67E-16 |
| M00147 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex | 10 | 3.7E-06 |
| M00101 | Cholesterol biosynthesis, squalene 2,3 | 9 | 1.62E-05 |
| M00146 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex | 10 | 0.00027 |
| M00142 | NADH: ubiquinone oxidoreductase, mitochondria | 6 | 0.000849 |
| dre04261 | Adrenergic signaling in cardiomyocytes | 43 | 0.002158 |
| dre04260 | Cardiac muscle contraction | 24 | 0.01052 |
| dre_M00148 | Succinate dehydrogenase (ubiquinone) | 4 | 0.029785 |
| dre04514 | Cell adhesion molecules (CAMs) | 28 | 0.048195 |
| dre04144 | Endocytosis | 58 | 0.048195 |
|
| |||
| dre03013 | RNA transport | 71 | 4E-22 |
| dre03008 | Ribosome biogenesis in eukaryotes | 47 | 7.96E-22 |
| dre03030 | DNA replication | 28 | 4.76E-16 |
| dre04141 | Protein processing in endoplasmic reticulum | 64 | 3.81E-14 |
| dre04110 | Cell cycle | 54 | 5.66E-14 |
| dre03460 | Fanconi anemia pathway | 28 | 1.72E-11 |
| dre03040 | Spliceosome | 43 | 4E-08 |
| dre00240 | Pyrimidine metabolism | 34 | 2.71E-06 |
| dre_M00693 | Cell cycle | 8 | 1.32E-05 |
| dre03018 | RNA degradation | 28 | 1.77E-05 |
There are KEGG terms of up-regulated and down-regulated DEGs in spinal cord injury. DEG: Differentially expressed genes; KEGG: Kyoto Encyclopedia of Genes and Genomes.